Deciphering lung adenocarcinoma heterogeneity: a multi-omics approach reveals nuclear division fibroblasts as prognosticators and therapeutic targets - PubMed
5 hours ago
- #Lung adenocarcinoma
- #Prognostic biomarkers
- #Fibroblasts
- Lung adenocarcinoma (LUAD) is a major cause of cancer-related deaths globally.
- Lung-associated fibroblasts (LAFs) play a significant role in tumorigenesis and the tumor microenvironment (TME).
- The study used a multi-omics approach to analyze LAF heterogeneity in LUAD.
- Data included bulk RNA from 2719 patients, scRNA sequencing from 368,904 cells, and spatial transcriptomics from 15,673 spots.
- Nine LAF subtypes were identified, with nuclear division LAFs (nLAFs) linked to LUAD prognosis.
- A five-gene nLAFs risk score (nLRS) model was developed using machine learning, outperforming 49 other models.
- High nLRS groups showed distinct biological functions and immune cell infiltration in the TME.
- High nLRS patients may resist immunotherapy but respond better to chemotherapy and targeted therapies.
- The study proposes a five-gene signature from nLAFs as a potential prognostic biomarker for LUAD.